COVID-19 and Cardiometabolic Health: Lessons Gleaned from the Pandemic and Insights for the Next Wave.

"Declarations Conflict of InterestDr. Navar reports grant support from BMS, Esperion, and Janssen; and consulting for Amarin, Amgen, AstraZeneca, BI, Bayer, CSL, Esperion, Janssen, Lilly, Sanofi, Regeneron, NovoNordisk, Novartis, The Medicines Company, New Amsterdam, Cerner, 80Bio, and Pfizer. Dr. Navar also reports leadership or fiduciary role in the American Society for Preventive Cardiology, the National Forum, and JAMA Cardiology. Dr. Khera reports leadership or fiduciary role in the American Society for Preventive Cardiology Board. The other authors declare that they have no conflict of interest. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest Dr. Navar reports grant support from BMS, Esperion, and Janssen; and consulting for Amarin, Amgen, AstraZeneca, BI, Bayer, CSL, Esperion, Janssen, Lilly, Sanofi, Regeneron, NovoNordisk, Novartis, The Medicines Company, New Amsterdam, Cerner, 80Bio, and Pfizer. Dr. Navar also reports leadership or fiduciary role in the American Society for Preventive Cardiology, the National Forum, and JAMA Cardiology. Dr. Khera reports leadership or fiduciary role in the American Society for Preventive Cardiology Board. The other authors declare that they have no conflict of interest."

"Dr. Kolkailah was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL125247. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health."